What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018. Read More

What are the significant segments operating in the market?

Market is segmented on the basis. Read More

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. Read More

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering. Read More

Global In Vitro Diagnostic/IVD Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publish Date: Mar, 2020
Report ID: 416028
Category: Pharmaceuticals and Healthcare
Pages: 102

$3480

Market Overview

The global In Vitro Diagnostic/IVD market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The In Vitro Diagnostic/IVD market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

In Vitro Diagnostic/IVD market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, In Vitro Diagnostic/IVD market has been segmented into:

Instruments

Reagents

By Application, In Vitro Diagnostic/IVD has been segmented into:

Diabetes

Oncology

Cardiology

Nephrology

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global In Vitro Diagnostic/IVD market presented in the report. This section sheds light on the sales growth of different regional and country-level In Vitro Diagnostic/IVD markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global In Vitro Diagnostic/IVD market.

The report offers in-depth assessment of the growth and other aspects of the In Vitro Diagnostic/IVD market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and In Vitro Diagnostic/IVD Market Share Analysis

In Vitro Diagnostic/IVD competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, In Vitro Diagnostic/IVD sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the In Vitro Diagnostic/IVD sales, revenue and market share for each player covered in this report.

The major players covered in In Vitro Diagnostic/IVD are:

Roche Diagnostics (Switzerland)

Sysmex Corporation (Japan)

Abbott Laboratories (US)

Siemens Healthineers (Germany)

Bio-Rad Laboratories (US)

Danaher Corporation (US)

DiaSorin (Italy)

Johnson and Johnson (US)

Thermo Fisher Scientific (US)

bioMÃ©rieux (France)

Ortho Clinical Diagnostics (US)

Agilent Technologies (US)

QIAGEN (Germany)

Request Sample Request for Customization

Table of Contents

1 In Vitro Diagnostic/IVD Market Overview

1.1 Product Overview and Scope of In Vitro Diagnostic/IVD

1.2 Classification of In Vitro Diagnostic/IVD by Type

1.2.1 Global In Vitro Diagnostic/IVD Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global In Vitro Diagnostic/IVD Revenue Market Share by Type in 2019

1.2.3 Instruments

1.2.4 Reagents

1.3 Global In Vitro Diagnostic/IVD Market by Application

1.3.1 Overview: Global In Vitro Diagnostic/IVD Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Diabetes

1.3.3 Oncology

1.3.4 Cardiology

1.3.5 Nephrology

1.4 Global In Vitro Diagnostic/IVD Market by Regions

1.4.1 Global In Vitro Diagnostic/IVD Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of In Vitro Diagnostic/IVD (2015-2025)

1.4.3 North America (USA, Canada and Mexico) In Vitro Diagnostic/IVD Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) In Vitro Diagnostic/IVD Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) In Vitro Diagnostic/IVD Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) In Vitro Diagnostic/IVD Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) In Vitro Diagnostic/IVD Status and Prospect (2015-2025)

2 Company Profiles

2.1 Roche Diagnostics (Switzerland)

2.1.1 Roche Diagnostics (Switzerland) Details

2.1.2 Roche Diagnostics (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Roche Diagnostics (Switzerland) SWOT Analysis

2.1.4 Roche Diagnostics (Switzerland) Product and Services

2.1.5 Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.2 Sysmex Corporation (Japan)

2.2.1 Sysmex Corporation (Japan) Details

2.2.2 Sysmex Corporation (Japan) Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Sysmex Corporation (Japan) SWOT Analysis

2.2.4 Sysmex Corporation (Japan) Product and Services

2.2.5 Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.3 Abbott Laboratories (US)

2.3.1 Abbott Laboratories (US) Details

2.3.2 Abbott Laboratories (US) Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Abbott Laboratories (US) SWOT Analysis

2.3.4 Abbott Laboratories (US) Product and Services

2.3.5 Abbott Laboratories (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.4 Siemens Healthineers (Germany)

2.4.1 Siemens Healthineers (Germany) Details

2.4.2 Siemens Healthineers (Germany) Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Siemens Healthineers (Germany) SWOT Analysis

2.4.4 Siemens Healthineers (Germany) Product and Services

2.4.5 Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.5 Bio-Rad Laboratories (US)

2.5.1 Bio-Rad Laboratories (US) Details

2.5.2 Bio-Rad Laboratories (US) Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Bio-Rad Laboratories (US) SWOT Analysis

2.5.4 Bio-Rad Laboratories (US) Product and Services

2.5.5 Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.6 Danaher Corporation (US)

2.6.1 Danaher Corporation (US) Details

2.6.2 Danaher Corporation (US) Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Danaher Corporation (US) SWOT Analysis

2.6.4 Danaher Corporation (US) Product and Services

2.6.5 Danaher Corporation (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.7 DiaSorin (Italy)

2.7.1 DiaSorin (Italy) Details

2.7.2 DiaSorin (Italy) Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 DiaSorin (Italy) SWOT Analysis

2.7.4 DiaSorin (Italy) Product and Services

2.7.5 DiaSorin (Italy) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.8 Johnson and Johnson (US)

2.8.1 Johnson and Johnson (US) Details

2.8.2 Johnson and Johnson (US) Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Johnson and Johnson (US) SWOT Analysis

2.8.4 Johnson and Johnson (US) Product and Services

2.8.5 Johnson and Johnson (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.9 Thermo Fisher Scientific (US)

2.9.1 Thermo Fisher Scientific (US) Details

2.9.2 Thermo Fisher Scientific (US) Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Thermo Fisher Scientific (US) SWOT Analysis

2.9.4 Thermo Fisher Scientific (US) Product and Services

2.9.5 Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.10 bioMÃ©rieux (France)

2.10.1 bioMÃ©rieux (France) Details

2.10.2 bioMÃ©rieux (France) Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 bioMÃ©rieux (France) SWOT Analysis

2.10.4 bioMÃ©rieux (France) Product and Services

2.10.5 bioMÃ©rieux (France) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.11 Ortho Clinical Diagnostics (US)

2.11.1 Ortho Clinical Diagnostics (US) Details

2.11.2 Ortho Clinical Diagnostics (US) Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Ortho Clinical Diagnostics (US) SWOT Analysis

2.11.4 Ortho Clinical Diagnostics (US) Product and Services

2.11.5 Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.12 Agilent Technologies (US)

2.12.1 Agilent Technologies (US) Details

2.12.2 Agilent Technologies (US) Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Agilent Technologies (US) SWOT Analysis

2.12.4 Agilent Technologies (US) Product and Services

2.12.5 Agilent Technologies (US) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

2.13 QIAGEN (Germany)

2.13.1 QIAGEN (Germany) Details

2.13.2 QIAGEN (Germany) Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 QIAGEN (Germany) SWOT Analysis

2.13.4 QIAGEN (Germany) Product and Services

2.13.5 QIAGEN (Germany) In Vitro Diagnostic/IVD Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global In Vitro Diagnostic/IVD Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 In Vitro Diagnostic/IVD Players Market Share

3.2.2 Top 10 In Vitro Diagnostic/IVD Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global In Vitro Diagnostic/IVD Revenue and Market Share by Regions

4.2 North America In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

4.3 Europe In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

4.5 South America In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

5 North America In Vitro Diagnostic/IVD Revenue by Countries

5.1 North America In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)

5.2 USA In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

5.3 Canada In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

5.4 Mexico In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

6 Europe In Vitro Diagnostic/IVD Revenue by Countries

6.1 Europe In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)

6.2 Germany In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

6.3 UK In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

6.4 France In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

6.5 Russia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

6.6 Italy In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

7 Asia-Pacific In Vitro Diagnostic/IVD Revenue by Countries

7.1 Asia-Pacific In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)

7.2 China In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

7.3 Japan In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

7.4 Korea In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

7.5 India In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

8 South America In Vitro Diagnostic/IVD Revenue by Countries

8.1 South America In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)

8.2 Brazil In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

8.3 Argentina In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue In Vitro Diagnostic/IVD by Countries

9.1 Middle East & Africa In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)

9.2 Saudi Arabia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

9.3 UAE In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

9.4 Egypt In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

9.5 South Africa In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global In Vitro Diagnostic/IVD Revenue and Market Share by Type (2015-2020)

10.2 Global In Vitro Diagnostic/IVD Market Forecast by Type (2019-2024)

10.3 Instruments Revenue Growth Rate (2015-2025)

10.4 Reagents Revenue Growth Rate (2015-2025)

11 Global In Vitro Diagnostic/IVD Market Segment by Application

11.1 Global In Vitro Diagnostic/IVD Revenue Market Share by Application (2015-2020)

11.2 In Vitro Diagnostic/IVD Market Forecast by Application (2019-2024)

11.3 Diabetes Revenue Growth (2015-2020)

11.4 Oncology Revenue Growth (2015-2020)

11.5 Cardiology Revenue Growth (2015-2020)

11.6 Nephrology Revenue Growth (2015-2020)

12 Global In Vitro Diagnostic/IVD Market Size Forecast (2021-2025)

12.1 Global In Vitro Diagnostic/IVD Market Size Forecast (2021-2025)

12.2 Global In Vitro Diagnostic/IVD Market Forecast by Regions (2021-2025)

12.3 North America In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)

12.4 Europe In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)

12.6 South America In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global In Vitro Diagnostic/IVD Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of In Vitro Diagnostic/IVD by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global In Vitro Diagnostic/IVD Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market In Vitro Diagnostic/IVD Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Roche Diagnostics (Switzerland) Corporate Information, Location and Competitors

Table 6. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Major Business

Table 7. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 8. Roche Diagnostics (Switzerland) SWOT Analysis

Table 9. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Product and Solutions

Table 10. Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 11. Sysmex Corporation (Japan) Corporate Information, Location and Competitors

Table 12. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Major Business

Table 13. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2018-2019)

Table 14. Sysmex Corporation (Japan) SWOT Analysis

Table 15. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Product and Solutions

Table 16. Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 17. Abbott Laboratories (US) Corporate Information, Location and Competitors

Table 18. Abbott Laboratories (US) In Vitro Diagnostic/IVD Major Business

Table 19. Abbott Laboratories (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 20. Abbott Laboratories (US) SWOT Analysis

Table 21. Abbott Laboratories (US) In Vitro Diagnostic/IVD Product and Solutions

Table 22. Abbott Laboratories (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 23. Siemens Healthineers (Germany) Corporate Information, Location and Competitors

Table 24. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Major Business

Table 25. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 26. Siemens Healthineers (Germany) SWOT Analysis

Table 27. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Product and Solutions

Table 28. Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 29. Bio-Rad Laboratories (US) Corporate Information, Location and Competitors

Table 30. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Major Business

Table 31. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 32. Bio-Rad Laboratories (US) SWOT Analysis

Table 33. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Product and Solutions

Table 34. Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 35. Danaher Corporation (US) Corporate Information, Location and Competitors

Table 36. Danaher Corporation (US) In Vitro Diagnostic/IVD Major Business

Table 37. Danaher Corporation (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 38. Danaher Corporation (US) SWOT Analysis

Table 39. Danaher Corporation (US) In Vitro Diagnostic/IVD Product and Solutions

Table 40. Danaher Corporation (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 41. DiaSorin (Italy) Corporate Information, Location and Competitors

Table 42. DiaSorin (Italy) In Vitro Diagnostic/IVD Major Business

Table 43. DiaSorin (Italy) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 44. DiaSorin (Italy) SWOT Analysis

Table 45. DiaSorin (Italy) In Vitro Diagnostic/IVD Product and Solutions

Table 46. DiaSorin (Italy) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 47. Johnson and Johnson (US) Corporate Information, Location and Competitors

Table 48. Johnson and Johnson (US) In Vitro Diagnostic/IVD Major Business

Table 49. Johnson and Johnson (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 50. Johnson and Johnson (US) SWOT Analysis

Table 51. Johnson and Johnson (US) In Vitro Diagnostic/IVD Product and Solutions

Table 52. Johnson and Johnson (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 53. Thermo Fisher Scientific (US) Corporate Information, Location and Competitors

Table 54. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Major Business

Table 55. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 56. Thermo Fisher Scientific (US) SWOT Analysis

Table 57. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Product and Solutions

Table 58. Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 59. bioMÃ©rieux (France) Corporate Information, Location and Competitors

Table 60. bioMÃ©rieux (France) In Vitro Diagnostic/IVD Major Business

Table 61. bioMÃ©rieux (France) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 62. bioMÃ©rieux (France) SWOT Analysis

Table 63. bioMÃ©rieux (France) In Vitro Diagnostic/IVD Product and Solutions

Table 64. bioMÃ©rieux (France) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 65. Ortho Clinical Diagnostics (US) Corporate Information, Location and Competitors

Table 66. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Major Business

Table 67. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 68. Ortho Clinical Diagnostics (US) SWOT Analysis

Table 69. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Product and Solutions

Table 70. Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 71. Agilent Technologies (US) Corporate Information, Location and Competitors

Table 72. Agilent Technologies (US) In Vitro Diagnostic/IVD Major Business

Table 73. Agilent Technologies (US) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 74. Agilent Technologies (US) SWOT Analysis

Table 75. Agilent Technologies (US) In Vitro Diagnostic/IVD Product and Solutions

Table 76. Agilent Technologies (US) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 77. QIAGEN (Germany) Corporate Information, Location and Competitors

Table 78. QIAGEN (Germany) In Vitro Diagnostic/IVD Major Business

Table 79. QIAGEN (Germany) In Vitro Diagnostic/IVD Total Revenue (USD Million) (2017-2018)

Table 80. QIAGEN (Germany) SWOT Analysis

Table 81. QIAGEN (Germany) In Vitro Diagnostic/IVD Product and Solutions

Table 82. QIAGEN (Germany) In Vitro Diagnostic/IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 83. Global In Vitro Diagnostic/IVD Revenue (Million USD) by Players (2015-2020)

Table 84. Global In Vitro Diagnostic/IVD Revenue Share by Players (2015-2020)

Table 85. Global In Vitro Diagnostic/IVD Revenue (Million USD) by Regions (2015-2020)

Table 86. Global In Vitro Diagnostic/IVD Revenue Market Share by Regions (2015-2020)

Table 87. North America In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)

Table 88. North America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)

Table 89. Europe In Vitro Diagnostic/IVD Revenue (Million USD) by Countries (2015-2020)

Table 90. Asia-Pacific In Vitro Diagnostic/IVD Revenue (Million USD) by Countries (2015-2020)

Table 91. South America In Vitro Diagnostic/IVD Revenue by Countries (2015-2020)

Table 92. South America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)

Table 93. Middle East and Africa In Vitro Diagnostic/IVD Revenue (Million USD) by Countries (2015-2020)

Table 94. Middle East and Africa In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)

Table 95. Global In Vitro Diagnostic/IVD Revenue (Million USD) by Type (2015-2020)

Table 96. Global In Vitro Diagnostic/IVD Revenue Share by Type (2015-2020)

Table 97. Global In Vitro Diagnostic/IVD Revenue Forecast by Type (2021-2025)

Table 98. Global In Vitro Diagnostic/IVD Revenue by Application (2015-2020)

Table 99. Global In Vitro Diagnostic/IVD Revenue Share by Application (2015-2020)

Table 100. Global In Vitro Diagnostic/IVD Revenue Forecast by Application (2021-2025)

Table 101. Global In Vitro Diagnostic/IVD Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. In Vitro Diagnostic/IVD Picture

Figure 2. Global In Vitro Diagnostic/IVD Revenue Market Share by Type in 2019

Figure 3. Instruments Picture

Figure 4. Reagents Picture

Figure 5. In Vitro Diagnostic/IVD Revenue Market Share by Application in 2019

Figure 6. Diabetes Picture

Figure 7. Oncology Picture

Figure 8. Cardiology Picture

Figure 9. Nephrology Picture

Figure 10. Global In Vitro Diagnostic/IVD Revenue (USD Million) and Growth Rate (2015-2025)

Figure 11. North America In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 12. Europe In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 13. Asia-Pacific In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 14. South America In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 15. Middle East and Africa In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. Global In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 17. Global In Vitro Diagnostic/IVD Revenue Share by Players in 2019

Figure 18. Global Top 5 Players In Vitro Diagnostic/IVD Revenue Market Share in 2019

Figure 19. Global Top 10 Players In Vitro Diagnostic/IVD Revenue Market Share in 2019

Figure 20. Key Players Market Share Trend

Figure 21. Global In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 22. Global In Vitro Diagnostic/IVD Revenue Market Share by Regions (2015-2020)

Figure 23. Global In Vitro Diagnostic/IVD Revenue Market Share by Regions in 2018

Figure 24. North America In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 25. Europe In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 26. Asia-Pacific In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 27. South America In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 28. Middle East and Africa In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 29. North America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)

Figure 30. North America In Vitro Diagnostic/IVD Revenue Market Share by Countries in 2019

Figure 31. USA In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 32. Canada In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 33. Mexico In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 34. Europe In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)

Figure 35. Europe In Vitro Diagnostic/IVD Revenue Market Share by Countries in 2019

Figure 36. Germany In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 37. UK In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 38. France In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 39. Russia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 40. Italy In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 41. Asia-Pacific In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)

Figure 42. Asia-Pacific In Vitro Diagnostic/IVD Revenue Market Share by Countries in 2019

Figure 43. China In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 44. Japan In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 45. Korea In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 46. India In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 47. Southeast Asia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 48. South America In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)

Figure 49. South America In Vitro Diagnostic/IVD Revenue Market Share by Countries in 2019

Figure 50. Brazil In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 51. Argentina In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 52. Middle East and Africa In Vitro Diagnostic/IVD Revenue Market Share by Countries (2015-2020)

Figure 53. Middle East and Africa In Vitro Diagnostic/IVD Revenue Market Share by Countries in 2019

Figure 54. Saudi Arabia In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 55. UAE In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 56. Egypt In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 57. South Africa In Vitro Diagnostic/IVD Revenue and Growth Rate (2015-2020)

Figure 58. Global In Vitro Diagnostic/IVD Revenue Share by Type (2015-2020)

Figure 59. Global In Vitro Diagnostic/IVD Revenue Share by Type in 2019

Figure 60. Global In Vitro Diagnostic/IVD Market Share Forecast by Type (2021-2025)

Figure 61. Global Instruments Revenue Growth Rate (2015-2020)

Figure 62. Global Reagents Revenue Growth Rate (2015-2020)

Figure 63. Global In Vitro Diagnostic/IVD Revenue Share by Application (2015-2020)

Figure 64. Global In Vitro Diagnostic/IVD Revenue Share by Application in 2019

Figure 65. Global In Vitro Diagnostic/IVD Market Share Forecast by Application (2021-2025)

Figure 66. Global Diabetes Revenue Growth Rate (2015-2020)

Figure 67. Global Oncology Revenue Growth Rate (2015-2020)

Figure 68. Global Cardiology Revenue Growth Rate (2015-2020)

Figure 69. Global Nephrology Revenue Growth Rate (2015-2020)

Figure 70. Global In Vitro Diagnostic/IVD Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 71. Global In Vitro Diagnostic/IVD Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 72. Global In Vitro Diagnostic/IVD Revenue Market Share Forecast by Regions (2021-2025)

Figure 73. North America In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)

Figure 74. Europe In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)

Figure 75. Asia-Pacific In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)

Figure 76. South America In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)

Figure 77. Middle East and Africa In Vitro Diagnostic/IVD Revenue Market Forecast (2021-2025)

Figure 78. Sales Channel: Direct Channel vs Indirect Channel

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

Market research helps businesses strengthen a company’s position
Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
Market research helps in identifying the potential threats and opportunities associated with the business industry
Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

Data Collection
Data Synthesis
Market Deduction & Formulation
Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends.
Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information.

We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:

Export & Import Data
Business Information related to trade and its statistics
Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.

In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
Examining demographic along with psychographic segmentation for market evaluation
Analyzing the macro and micro-economic indicators for each demography
Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology.

Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.

The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample

Full Name

Country

Phone

Company

Designation

Comment

Human Verification

Our Clients

Choose License Type

For more information

Have a Question? Email us at

sales@fiormarkets.com

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Testimonials

Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –

Kennedy Brown
Health Technology Innovation
United States

Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance

Mika Salomäki

Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.

ONDŘEJ ŠUPKA
Analytics Department
ČESKÁ ZBROJOVKA A.S.

Dear Siddhartha,
The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us.
Thanks for all your help!